FDA, AstraZeneca prep for oncology adcomm
The FDA is set to convene its first advisory meeting of oncology experts in about nine months, with a couple of AstraZeneca drugs as the focus of the discussion. Details about the meeting of the ...
April 29, 2026 02:32 PM EDT R&DPharmaFDA+ FDA revives oncology advisory panel to debate AstraZeneca drugs Max Bayer Senior Reporter The FDA is set to convene its first advisory meeting of oncology experts in about nine months, with a couple of AstraZeneca drugs as the … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
comments(0)
5-min edit window · permanent after that